AstraZeneca says its COVID shot has market potential despite lower demand
AstraZeneca has started earning a modest profit on the vaccine, which was initially sold at-cost. However, the British drugmaker…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
mRNA vaccines
Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029
The five-year contract allows for production of up to 80 million doses at short notice until 2029, CureVac said, adding that those…
Moderna finalises strategic partnership with Australian government
On-shore manufacturing facility based in Melbourne, Australia, expected to produce up to 100 million mRNA respiratory vaccine…
UK researchers developing new COVID-19 vaccines
The research project will boost the UK’s and the world’s ability to rapidly develop new vaccines in response to new variants of…
Scientists develop molecule that blocks COVID-19 infection
The researchers at Aarhus University in Denmark noted that the molecule is cheaper and easier to manufacture than the antibodies…
Ignite Life Science Foundation announces grant for developing mRNA vaccine technology
A grant of three years was awarded to the Indian Institute of Science (Bangalore) and the Translational Health Science and…
Biological E to produce Providence Therapeutics’ mRNA COVID-19 vaccine in India
It targets one billion dose production capacity in 2022
Merck launches synthetic cholesterol product to meet high demand for lipids
This neutral lipid, used in commercially marketed products, is more than 99 per cent pure; offers high batch-to-batch consistency…
CMOs gain advantages of COVID-19 production and timescale demands: GlobalData
CMOs signed contract manufacturing service agreements at an unprecedented rate in 2020, says GlobalData